A multicenter, randomized, double-blind, placebo-controlled trial for Lu-Dang-Shen oral liquid in the treatment of reduced digestion function of convalescent new coronavirus pneumonia (COVID-19) patient
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003304
- Lead Sponsor
- Wuhan Third Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Meet the diagnostic criteria of the n Novel Coronavirus Pneumonia (COVID-19) in the recovery period;
2. Patients with fatigue, anorexia, abdominal distension, loose stools and other digestive dysfunction as the main clinical manifestations, 3 of them at the same time, or a single symptom visual analog score (VAS) greater than 5 points;
3. Heal patients who have been discharged for more than 2 weeks;
4. Aged 18-70 years old;
5. Sign the informed consent.
1. Patients with fatigue, anorexia, abdominal distension, loose stools due to other reasons or diseases of the digestive system;
2. Patients with difficulties in taking oral drugs due to underlying diseases and other reasons;
3. It is accompanied by serious basic diseases that affect survival, including uncontrolled clinically meaningful heart, lung, kidney, digestion, blood disease, neuropsychiatric disease, immune disease, metabolic disease, malignant tumor, severe malnutrition, etc ;
4. People with allergies and allergies to the drugs involved in the treatment plan;
5. Women during pregnancy or lactation;
6. Those who cannot cooperate with their mental state, those who suffer from mental illness, lack self-control, and cannot express clearly;
7. Those who are participating in other clinical trials;
8. According to the judgment of the investigator, there will be patients who are complicated to enroll or have poor compliance, etc., which affect the efficacy and safety evaluation.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the degree of clinical symptoms such as fatigue, poor appetite, abdominal distension, and loose stools caused by decreased digestive function of the two groups of subjects;
- Secondary Outcome Measures
Name Time Method